The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York WHAT ARE THE NEGATIVE SIDE EFFECTS OF PEPTIDE THERAPY IN CHARLESTON, SC? CHARLESTON HEALTHSPAN INSTITUTE Glow Peptide Protocol GHK Cu, BPC 157, TB 500 Neurogan Health BPC 157: Experimental Peptide Creates Risk for Athletes